Paxlovid for Treatment of Long Covid

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

August 14, 2023

Study Completion Date

September 12, 2023

Conditions
Post-acute Sequelae of SARS-CoV-2 InfectionLong COVID
Interventions
DRUG

Nirmatrelvir

Two 150 mg tablets taken by mouth every 12 hours

DRUG

Placebo

Two tablets containing placebo matching nirmatrelvir taken by mouth every 12 hours

DRUG

Ritonavir

One 100 mg capsule taken by mouth every 12 hours

Trial Locations (1)

94305

Stanford University, Stanford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Stanford University

OTHER

NCT05576662 - Paxlovid for Treatment of Long Covid | Biotech Hunter | Biotech Hunter